Effects of atomoxetine on attention-deficit/hyperactivity disorder in clinical pediatric treatment settings: a naturalistic study

Current Medical Research and Opinion
Rosalie J BakkenDouglas Kelsey

Abstract

Observational studies involving atomoxetine hydrochloride in the treatment of attention-deficit/hyperactivity disorder (ADHD) complement randomized controlled trials by assessing treatment effects in a usual-care setting and including a more heterogeneous patient population. To provide data on the effectiveness of atomoxetine in a naturalistic treatment setting according to both physician and parent ratings. A prospective, observational (non-interventional), longitudinal, open-label study of patients (N = 627; mean age = 11 years) with ADHD (from 60 physicians' offices in the United States and Puerto Rico) whose physicians had decided to prescribe atomoxetine either as initial treatment or after trying another ADHD treatment (e.g., stimulants, antidepressants). Patients with a baseline visit and one post-baseline visit for up to 1 year were eligible. Atomoxetine administration, dosing, and timing of follow-up visits were at each physician's discretion. Physicians evaluated the effectiveness of atomoxetine using a single-item rating scale: the Physician Global Impression: ADHD Severity (PGI-ADHD-S) scale. The average reported duration of treatment was 21.2 (range 0-89) weeks. Over this period, treatment significantly lowered ADH...Continue Reading

References

Feb 1, 1991·Journal of Abnormal Child Psychology·R LoeberM Stouthamer-Loeber
May 11, 1996·BMJ : British Medical Journal·N Black
Apr 1, 1996·Journal of the American Academy of Child and Adolescent Psychiatry·T SpencerS Griffin
Oct 12, 1999·Journal of the American Academy of Child and Adolescent Psychiatry·P CorkumR Tannock
Dec 11, 1999·Archives of Pediatrics & Adolescent Medicine·J M ZitoD A Zarin
Mar 14, 2000·Journal of the American Academy of Child and Adolescent Psychiatry·E M MitsisJ M Halperin
Mar 27, 2001·Journal of Developmental and Behavioral Pediatrics : JDBP·P S JensenT Wigal
Oct 3, 2001·Pediatrics·UNKNOWN American Academy of Pediatrics. Subcommittee on Attention-Deficit/Hyperactivity Disorder and Committee on Quality Improvemen
Nov 24, 2001·BMJ : British Medical Journal·J P Guevara, M T Stein
Jan 28, 2003·Biological Psychiatry·David MichelsonDenái Milton
Jun 5, 2003·The American Journal of Psychiatry·Mark OlfsonPeter S Jensen
Jun 24, 2004·Journal of the American Academy of Child and Adolescent Psychiatry·Howard AbikoffSimcha Pollack
Jun 24, 2004·Journal of the American Academy of Child and Adolescent Psychiatry·David MichelsonJoseph Biederman
Jan 14, 2005·The New England Journal of Medicine·Marsha D Rappley
Dec 21, 2006·European Child & Adolescent Psychiatry·A RothenbergerH C Steinhausen
Dec 21, 2006·European Child & Adolescent Psychiatry·Hans-Christoph SteinhausenUNKNOWN ADORE Study Group

❮ Previous
Next ❯

Citations

Oct 23, 2012·Journal of Child and Adolescent Psychopharmacology·Chi-Yung Shang, Susan Shur-Fen Gau
Oct 30, 2008·Child and Adolescent Psychiatry and Mental Health·David CoghillJan Buitelaar
Jun 27, 2009·Neuropsychiatric Disease and Treatment·Paul HammernessDaniel Geller
Dec 4, 2019·Journal of Child and Adolescent Psychopharmacology·Chi-Yung ShangSusan Shur-Fen Gau
Dec 14, 2011·The Cochrane Database of Systematic Reviews·Tao HuangDaniel Kl Cheuk
Jun 19, 2021·Journal of Child and Adolescent Psychopharmacology·Nermin M ShakerDina Aly El-Gabry

❮ Previous
Next ❯

Related Concepts

Related Feeds

Attention Disorders

Attention is involved in all cognitive activities, and attention disorders are reported in patients with various neurological diseases. Here are the latest discoveries pertaining to attention disorders.